Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/26/26 16:40 | 2/24/26 | CTNM | Health | Drug | Pharmaceutical Preparations | Stengone Carmine N. | CA | DO | CEO,P | 4 | M.dm | 130 | 8.64 | 0 | 15 | 15 | D | |||||||||||||||
2/26/26 16:40 | 2/24/26 | CTNM | Health | Drug | Pharmaceutical Preparations | Stengone Carmine N. | CA | DO | CEO,P | 4 | S.dm | -130 | 8.64 | 0 | -15 | 15 | D | |||||||||||||||
2/26/26 16:39 | 2/24/26 | CTNM | Health | Drug | Pharmaceutical Preparations | Lorrain Daniel S. | CA | O | Chief Sc | 9 | M.dm | 304 | 10.21 | 0 | 30 | 21 | 171 | D | ||||||||||||||
2/26/26 16:39 | 2/24/26 | CTNM | Health | Drug | Pharmaceutical Preparations | Lorrain Daniel S. | CA | O | Chief Sc | 9 | S.dm | -304 | 10.21 | 0 | -30 | 171 | D | |||||||||||||||
1/30/26 16:52 | 1/28/26 | CTNM | Health | Drug | Pharmaceutical Preparations | Watkins Tim | CA | O | CMO,Head | 4 | M.d | 127 | 8.81 | 0 | 14 | 0 | D | |||||||||||||||
1/30/26 16:52 | 1/28/26 | CTNM | Health | Drug | Pharmaceutical Preparations | Watkins Tim | CA | O | CMO,Head | 4 | S.d | -127 | 8.81 | 0 | -14 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |